Pro-inflammatory pathways, including IL-1β/IL-6 signaling, NLRP3 inflammasome activation, and JAK2-mediated thrombo-inflammation, explain its role in atherosclerosis, metabolic dysfunction, and thrombotic risk, highlighting druggable targets for prevention. This evidence concerns the gene IL6 and atherosclerosis.